Melina Cioffi

CIK: 0002066841

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AQST

Aquestive Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

AQST
Aquestive Therapeutics, Inc.
May 15, 2026
Tax Payment(F)
Direct
1.7K shares at avg. $4.17$7K
AQST
Aquestive Therapeutics, Inc.
Mar 10, 2026
Sale(S)
Direct
25.3K shares at avg. $4.17$106K
AQST
Aquestive Therapeutics, Inc.
Mar 9, 2026
Award(A)
Direct
100K shares-
AQST
Aquestive Therapeutics, Inc.
Dec 2, 2025
Tax Payment(F)
Direct
2.1K shares at avg. $5.93$12K
AQST
Aquestive Therapeutics, Inc.
May 15, 2025
Award(A)
Direct
20K shares-

		Type	Shares	Price		Ownership
May 15, 2026	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	1,667	$4.17	$6,951	Direct
Mar 10, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	25,311	$4.17	$105,623	Direct
Mar 9, 2026	AQST Aquestive Therapeutics, Inc.	Award(A)	100,000	-	$0	Direct
Dec 2, 2025	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	2,083	$5.93	$12,352	Direct
May 15, 2025	AQST Aquestive Therapeutics, Inc.	Award(A)	20,000	-	-	Direct

1-5 of 5 transactions

About Cioffi Melina

Cioffi Melina (SEC CIK 0002066841) files insider reports with the SEC as SVP, Regulatory Affairs of Aquestive Therapeutics, Inc. (AQST).

Signal8 holds 5 ownership filings by Cioffi Melina (1 Form 3, 4 Form 4), filed between May 7, 2025 and May 18, 2026. Those filings report 5 transactions, from May 15, 2025 to May 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cioffi Melina's filings is in WARREN, NJ.

Recent filings by Cioffi Melina

May 15, 2026: Tax withholding of AQST shares (Form 4, code F).
Mar 10, 2026: Open-market sale of AQST shares (Form 4, code S).
Mar 9, 2026: Grant or award of AQST shares (Form 4, code A).
Dec 2, 2025: Tax withholding of AQST shares (Form 4, code F).
May 15, 2025: Grant or award of AQST shares (Form 4, code A).

Other insiders filing for Aquestive Therapeutics, Inc. (AQST)

Cochran John, Director
Barber Daniel, President and CEO
Daly Richard J, Director
Korczynski Sherry, Chief Commercial Officer
Boyd Peter E., Chief People Officer
Jung Cassie, Chief Operating Officer

How to read Form 4 transaction codes